Regulatory Intelligence Knowledge Hub

Insights for Medical Device Professionals

Practical PMS guidance for FDA and Health Canada first — with selected global reference content where useful. Written from the RA/QA perspective.

45 articles|4-level explanations
social_linkedinApril 4, 20261 min read8 related signals

Management review is next week. ISO 13485 5.6 requires external signal data as input. Your team hasn't gathered it yet, and you're staring at a blank slide for the board report on risk exposure and co

Here's what's happening right now: There were 10,384 new regulatory signals today, including 10,360 FDA Adverse Event Reports (MAUDE/MDRs) and 22 Health Canada mdl entries. Notably, Health Canada issued 2 new recalls: Auro-Canagliflozin for incorrect DIN labeling and LUXA-D for a foreign product in a capsule, both flagged for product safety. For your management review under QMSR and 21 CFR 820, this data isn't just noise—it's critical for quantifying risk exposure and benchmarking against compe

vp_qualitysocial
Read
social_linkedinApril 4, 20261 min read8 related signals

Complaint trends are rising for one product family but you can't tell if it's an industry-wide issue or yours alone. You're reviewing your CAPA dashboard, trying to prioritize investigations against l

Here's what's happening right now: 10,384 new regulatory signals hit the system today. That includes 10,360 new FDA adverse event reports (MAUDE/MDRs) and 2 new Health Canada recalls. One recall involves incorrect DIN labeling on a blister card (Auro-Canagliflozin), and another involves a foreign product in a capsule batch (LUXA-D). For your CAPA prioritization and complaint handling, notice the pattern in the MDRs: multiple reports for infusion set tubing detachment events and software/app mal

qa_engineersocial
Read
social_linkedinApril 4, 20261 min read8 related signals

A competitor's device just got recalled. Your auditor will ask: 'How did you evaluate whether this affects your products?' You're reviewing the alert, knowing it could trigger a supplier audit or requ

Here's what's happening right now: 2 new Health Canada recalls were issued this week, both for product safety issues. Auro-Canagliflozin has affected lots with incorrect DIN labeling on blister cards, and LUXA-D has a capsule containing a foreign product in the batch. This adds to 10,360 new FDA Adverse Event Reports (MAUDE/MDRs) and 22 new Health Canada mdl signals today, totaling 10,384 new regulatory signals. For RA Managers focused on audit preparedness and post-market surveillance, these s

ra_managersocial
Read
social_linkedinMarch 29, 20261 min read6 related signals

The board wants a single number for regulatory risk exposure. Your quality team gives you a spreadsheet with 200 rows and no summary. You're staring at disparate data points, trying to distill it into

Here's what's happening right now: As of March 29, 2026, there are 26,202 new regulatory signals in the market. This includes 26,000 new FDA Adverse Event Reports (MAUDE/MDRs) and 202 new Health Canada mdl entries. These numbers represent the raw volume of post-market activity you need to contextualize for risk assessment and compliance reporting. For a VP Quality/Regulatory, this data isn't just noise—it's critical for quantifying risk exposure and informing your board. The surge in adverse ev

vp_qualitysocial
Read
social_linkedinMarch 29, 20261 min read6 related signals

Root cause analysis keeps landing on the same categories: software, components, design. But which one actually needs CAPA resources first? You're reviewing this week's nonconformance trends, trying to

Here's what's happening right now: 26,202 new regulatory signals hit the system today. Among the high-priority FDA Adverse Event Reports, we see multiple malfunctions in insulin pumps (Tandem Diabetes Care's t:slim X2 with Control-IQ Technology) and video systems (Shirakawa Olympus's Visera Video System Center and Camera Head). The Olympus investigation specifically noted "a root cause could not be identified" with the most probable cause traced to "component failure." For CAPA prioritization u

qa_engineersocial
Read
social_linkedinMarch 29, 20261 min read6 related signals

New QMSR requirements changed the documentation expectations. Your procedures reference the old QSR. The gap analysis hasn't started, and you're prioritizing which updates will impact your next audit

Here's what's happening right now: Today alone, we tracked 26,202 new regulatory signals, including 26,000 new FDA Adverse Event Reports (MAUDE/MDRs) and 202 new Health Canada mdl entries. This volume underscores the critical need for robust post-market surveillance systems that align with updated QMSR and ISO 13485:2016 frameworks. For RA Managers focused on audit preparedness and QMSR compliance, this data signals a heightened focus on documentation and risk management. The surge in adverse e

ra_managersocial
Read
social_linkedinMarch 25, 20261 min read3 related signals

A labeling recall hit a competitor using the same contract packager. Your labeling uses the same supplier. Is a proactive review justified? You're weighing the risk of a supplier-driven CAPA against t

Here's what's happening right now: 35 new FDA enforcement actions were issued this week. Among them, a recall for the Penner Pacific Bathing Spa due to missing UDI labeling, and multiple recalls for the Raz Mobile Shower Commode Chair series stemming from a vendor modification that led to improper installation of seat brackets. These signals highlight immediate supplier and labeling risks. For Operations Managers focused on 21 CFR 820.50 supplier controls, this data underscores a critical patte

operationssocial
Read
social_linkedinMarch 25, 20261 min read3 related signals

Your competitor just announced a voluntary recall. The CEO asks: 'Are we exposed to the same issue?' You have 2 hours to answer. This is the reality of modern post-market surveillance, where vendor ch

Here's what's happening right now: 35 new FDA enforcement actions were published this week. Among them, a critical pattern emerges: 5 distinct models of Raz Mobile Shower Commode Chairs (Z300, Z333, Z360, Z200, Z100) were recalled due to a vendor modification causing improper seat bracket engagement. Simultaneously, GEM Premier 5000 systems face Process Control Solution Not Detected errors in their PAK cartridges, with two separate recalls (Part No. 00055415008 and 00055360004) highlighting the

vp_qualitysocial
Read
social_linkedinMarch 25, 20261 min read3 related signals

You're preparing a 510(k) submission and your predicate device was just recalled. Does your submission strategy need to change? Your design inputs and risk analysis now have a critical new data point

Here's what's happening right now: 35 new FDA enforcement actions were issued today. While the specific device categories aren't detailed in today's signal, this volume indicates active regulatory scrutiny across the medical device landscape. For design engineers, this means your predicate device selection process just got more complex. A recall on your chosen predicate directly impacts your 510(k) substantial equivalence argument and requires immediate updates to your design history file under

design_engineersocial
Read
social_linkedinMarch 1, 20261 min read12 related signals

Manufacturing nonconformance rates ticked up this quarter. Is it your process, your supplier, or an industry-wide material problem? You're reviewing CAPA data, trying to pinpoint whether to tighten in

Here's what's happening right now: 391 new FDA recalls were issued this week, with a significant cluster in convenience kits used for dialysis maintenance. Specific examples include Medline's ADD A CATH DIALYSIS KIT (SKU ECVC8415A) and Centurion's CENTRAL LINE INSERTION TRAY (SKU DT19810), where silicone seal failures in Tego Connectors are causing occluded fluid paths and therapy delays. Health Canada added 5 more recalls, including labeling issues with Sterile Contro-Vac suction catheters. Fo

operationssocial
Read
PreviousPage 1 of 3Next

See Your PMS Snapshot

Enter your device and see what needs review

Insights — PMS Guidance for FDA & Health Canada | TrueMedDevice